Author
Zi‐Wei Ye
Also Known As
Ye, Zi, Ye, Zi-wei, Ye, Ziwei, Z.W. Ye, Zhexuan Ye, Zi -Wei Ye, Zi Ye, Zi-Wei Ye, Zi-wei Ye, Ziwei Ye
140
Publications
6.3K
Citations
34
H-Index
124
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 18 | 22 | 2.4K |
2 | Engineering | 5 | 5 | 130 |
3 | Natural Sciences | 5 | 5 | 229 |
4 | Management | 1 | 1 | 32 |
5 | Public Health | 1 | 1 | 27 |
Zi‐Wei Ye
×
58
Publications
3.7K
Citations
29
H-Index
| Year | Citations | |
|---|---|---|
2020 | 751 | |
2019 | 513 | |
2019 | 250 | |
2022 | 215 | |
2021 | 200 | |
2020 | 193 | |
2018 | 86 | |
2014 | 71 | |
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system Shuofeng Yuan, Jasper Fuk‐Woo Chan, Kenn Ka-Hang Chik, Drug SafetyFda-approved Drugs BexarotenePreclinical Drug EvaluationMedicineAntiviral Therapy | 2020 | 71 |
2020 | 63 |
Page 1
Page 1